Date: October 05, 2026

Business Update for Q2 FY27

Operational Performance

  • Revenue grew by approximately 15% year-over-year (YoY) for the quarter ended September 30, 2026
  • Growth was primarily driven by double-digit patient volume growth and test volume growth
  • Improved realizations and change in product mix contributed to revenue growth

Segment Performance

  • TruHealth Wellness segment emerged as one of the fastest-growing segments during the quarter
  • Specialty segments also emerged as one of the fastest-growing segments during the quarter

Financial Performance

  • EBITDA margins improved meaningfully on both year-over-year (YoY) and quarter-over-quarter (QoQ) basis
  • Margin improvement was driven by operating leverage and efficiency gains

Additional Information

  • The business update is provided on a consolidated basis
  • Financial results for Q2 FY27 are subject to review by Auditors
  • Detailed financial information will follow after Board of Directors approval
  • The update is provided in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Also complies with Code of Fair Disclosure of Unpublished Price Sensitive Information & Policy for Legitimate Purpose under Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015